In Brief: Aloe Vera
This article was originally published in The Rose Sheet
Executive Summary
Aloe Vera: OTC "feedback" meeting scheduled for Aug. 30 between FDA and the International Aloe Science Council, Inc. has been postponed. The council had planned to discuss recent studies on the therapeutic benefits of aloe vera as well as update the agency on efforts to develop identity standards ("The Rose Sheet" July 31, In Brief)...